Qingdao VLAND Biotech INC. (603739.SH) plans to reduce the capital of its subsidiary Weilan Zhichong by 60 million yuan.

Qingdao Vland Biotech INC. (603739.SH) announced that, according to the company's future development plan and actual project needs, the company held the fifteenth meeting of the fifth board of directors on December 27, 2024, and approved the "Proposal on Capital Reduction for Wholly-owned Subsidiary". The company plans to reduce the capital of its wholly-owned subsidiary Qingdao Vland Pet Biotechnology Co., Ltd. (referred to as "Vland Pet") by 60 million yuan. After this capital reduction is completed, Vland Pet's registered capital will be reduced from 70 million yuan to 10 million yuan.